SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Overturf G.D.)
 

Sökning: WFRF:(Overturf G.D.) > Twelve years of flu...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00013375naa a2201501 4500
001oai:DiVA.org:liu-45812
003SwePub
008091011s2004 | |||||||||||000 ||eng|
024a https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-458122 URI
024a https://doi.org/10.1111/j.1470-9465.2004.t01-1-00844.x2 DOI
040 a (SwePub)liu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Pfaller, M.A.u Department of Pathology, Roy J./Lucille A. Carver Coll. Med., University of Iowa, Iowa City, IA 52242, United States, Department of Medicine, Roy J./Lucille A. Carver Coll. Med., University of Iowa, Iowa City, IA 52242, United States, Department Epidemiology, Roy J./Lucille A. Carver Coll. Med., University of Iowa, Iowa City, IA 52242, United States, Medical Microbiology Division, Department of Pathology, Univ. of Iowa College of Medicine, Iowa City, IA 52242, United States4 aut
2451 0a Twelve years of fluconazole in clinical practice :b Global-trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida
264 1b Elsevier BV,c 2004
338 a print2 rdacarrier
520 a We determined the species distribution and in-vitro susceptibility of 6082 bloodstream infection (BSI) isolates of Candida spp. collected from 250 medical centres in 32 nations over a 10-year period from 1992 through 2001. The species included 3401 C. albicans, 984 C. glabrata, 796 C. parapsilosis, 585 C. tropicalis, 153 C. krusei, 67 C. lusitaniae, 48 C. guilliermondii, 10 C. famata, 10 C. kefyr, six C. pelliculosa, five C. rugosa, four C. lipolytica, three C. dubliniensis, three C. inconspicua, two C. sake and one isolate each of C. lambica, C. norvegensis and C. zeylanoides. Minimum inhibitory concentration determinations were made using the National Committee for Clinical Laboratory Standards reference broth microdilution method. Variation in the rank order and frequency of the different species of Candida was observed over time and by geographic area. The proportion of BSI due to C. albicans and C. glabrata increased and C. parapsilosis decreased over time in Canada, the USA and Europe. C. glabrata was an infrequent cause of BSI in Latin America and the Asia-Pacific region. Very little variation in fluconazole susceptibility was observed among isolates of C. albicans, C. tropicalis and C. parapsilosis. These species accounted for 78% of all BSI and remained highly susceptible (91-100% susceptible) to fluconazole from 1992 to 2001 irrespective of geographic origin. The prevalence of fluconazole resistance among C. glabrata isolates was variable both over time and among the various countries and regions. Resistance to fluconazole among C. glabrata isolates was greatest in the USA and varied by US census region (range 0-23%). These observations are generally encouraging relative to the sustained usefulness of fluconazole as a systemically active antifungal agent for the treatment of candida BSI. © 2004 Copyright by the European Society of Clinical Microbiology and Infectious Diseases.
653 a Candidemia
653 a Fluconazole
653 a Surveillance
653 a NATURAL SCIENCES
653 a NATURVETENSKAP
700a Diekema, D.J.u Department of Pathology, Roy J./Lucille A. Carver Coll. Med., University of Iowa, Iowa City, IA 52242, United States, Department of Medicine, Roy J./Lucille A. Carver Coll. Med., University of Iowa, Iowa City, IA 52242, United States4 aut
700a Steele-Moore, L.u Christiana Care Health Services, Wilmington, DE, United States4 aut
700a Denys, G.u Clarion Health Methodist Hospital, Indianapolis, IN, United States4 aut
700a Staley, C.u Henry Ford Hospital, Detroit, MI, United States4 aut
700a Dipersio, J.R.u Suma Health System, Akron, OH, United States4 aut
700a Saubolle, M.u Good Samaitan Regional Medical Ctr., Phoenix, AZ, United States4 aut
700a Wilson, M.L.u Denver General Hospital, Denver, CO, United States4 aut
700a Overturf, G.D.u University of New Mexico Hospital, Albuquerque, NM, United States4 aut
700a Peterson, L.R.u North-western Memorial Hospital, Chicago, IL, United States4 aut
700a Schreckenberger, P.C.u University of Illinois at Chicago, Chicago, IL, United States4 aut
700a Doern, G.V.u University of Iowa Hospitals/Clinics, Iowa City, IA, United States4 aut
700a Cavalieri, S.u Creighton University, Omaha, NE, United States4 aut
700a Kehl, S.u Froedtert Memorial Lutheran Hosp.-E., Milwaukee, WI, United States4 aut
700a Brecher, S.u Boston VAMC, Boston, MA, United States4 aut
700a Lee, L.u Columbia Presbyterian Medical Center, New York, NY, United States4 aut
700a Isenberg, H.u Long Island Jewish Medical Center, New Hyde Park, NY, United States4 aut
700a Hardy, D.u Strong Memorial Hospital, Rochester, NY, United States4 aut
700a Koga, D.S.u St Jude Medical Center, Fullerton, CA, United States4 aut
700a Fusco, J.u Kaiser Regional Laboratory, Berkeley, CA, United States4 aut
700a Hoffmann, M.u Sacred Heart Medical Center, Spokane, WA, United States4 aut
700a Swanzy, S.u Univ. of Washington Medical Center, Seattle, WA, United States4 aut
700a Murray, P.R.u Barnes-Jewish Hospital, St Loouis, MO, United States4 aut
700a Southern, P.u Parkland Health/Hospital System, Dalls, TX, United States4 aut
700a Wanger, A.u University of Texas Medical School, Houston, TX, United States4 aut
700a Reisner, B.u Univ. Texas Med. Branch at Galveston, Galveston, TX, United States4 aut
700a Snyder, J.u University of Louisville Hospital, Louisville, KY, United States4 aut
700a Jenkin, S.u Carolinas Medical Center, Charlotte, NC, United States4 aut
700a Hazen, K.u Univ. of Virginia Medical Center, Charlottesville, VA, United States4 aut
700a Rennie, R.u University of Alberta Hospital, Edmonton, Alta., Canada4 aut
700a Hoban, D.u Health Sciences Center, Winnipeg, Man., Canada4 aut
700a Davidson, R.u Queen Elizabeth II Hlth. Sci. Ctr., Halifax, NS, Canada4 aut
700a Toye, B.u Ottawa General Hospital, Ottawa, Ont., Canada4 aut
700a Simor, A.u Sunnybrook Health Science Center, Toronto, Ont., Canada4 aut
700a Richardson, S.u Hospital for Sick Children, Toronto, Ont., Canada4 aut
700a Robson, H.u Royal Victoria Hospital, Montreal, Que., Canada4 aut
700a Smayvsky, J.u Microbiology Laboratory C.E.M.I.C, Buenos Aires, Argentina4 aut
700a Casellas, J.M.u Centro de Estudios Antimicrobianos, Buenos Aires, Argentina4 aut
700a Sampaio, J.L.M.u Lamina LTDA, Rio De Janeiro, Brazil4 aut
700a Prado, V.u Unidad De Microbiologia Oriente, Santiago, Chile4 aut
700a Garcia, P.u Centro Diagnostico, Santiago, Chile4 aut
700a Robledo, J.A.u Corp. Para Investig Biblogicag, Medellin, Colombia4 aut
700a Osornio, J.S.u Istituto Nacional de la Nutricion, Mexico City, Mexico4 aut
700a Zoccoli, C.u Laboratorio Medico Santa Luzia, Florianopolis, Brazil4 aut
700a Reis, A.u Federal Llhiversity of Sao Paulo, Sao Paulo, Brazil4 aut
700a Guzman, M.u Centro Medico De Caracas, San Bernadino, Caracas, Venezuela4 aut
700a Schwab, D.A.u Pathology Medical Laboratories, San Diego, CA, United States4 aut
700a Carroll, K.u University Utah Hospitals/Clinics, Salt Lake City, UT, United States4 aut
700a Chapin-Robertson, K.u Lahey Clinic, Burlington, MA, United States4 aut
700a Bourbeau, P.u Geisinger Medical Center, Danville, PA, United States4 aut
700a Sharp, S.E.u Mount Sinai Medical Center, Miami Beach, FL, United States4 aut
700a Barth, A.L.u Hospital de Clinicas de Porto Alegre, Porto Alegra, Brazil4 aut
700a Struelens, M.J.u Hospital de Clinicas de Porto Alegre, Porto Alegra, Brazil4 aut
700a Jarlier, V.u Hospital Erasem, Brussels, Belgium4 aut
700a Nguyen, J.u Hospital Erasem, Brussels, Belgium4 aut
700a Roussel-Delvallez, M.u Hospital de la Pitie-Salpitriere, Paris, France4 aut
700a Legakis, N.u National Univ. of Athens Med. Sch., Athens, Greece4 aut
700a Keller, N.u Chaim Sheba Medical Center, Tel Hashomer, Israel4 aut
700a Pascual, A.u University Hospital V. de Macarena, Sevilla, Spain4 aut
700a Linares, J.u Hospital de Bellvitge, Barcelona, Spain4 aut
700a Canton, R.u Hospital Ramon y Cajal, Madrid, Spain4 aut
700a Prapian, F.u University Hospital, Lausanne, Switzerland4 aut
700a Bille, J.u University Hospital, Lausanne, Switzerland4 aut
700a Gur, D.u Hacettepe Universitaesi, Tip Fakultesi, Ankara, Turkey4 aut
700a Korten, V.u Marmara-Universitesi, Tip Fakultesi, Istanbul, Turkey4 aut
700a Mulazimoglu, L.u Marmara-Universitesi, Tip Fakultesi, Istanbul, Turkey4 aut
700a Unal, S.u Hacettepe Universitaesi, Tip Fakultesi, Ankara, Turkey4 aut
700a Kocagoz, S.u Hacettepe Universitaesi, Tip Fakultesi, Ankara, Turkey4 aut
700a Debbia, E.u Universita degli Studi di Genova, Genova, Italy4 aut
700a French, G.u St Thomas Hospital, London, United Kingdom4 aut
700a Etienne, J.u Hopital Rdouard Heriot, Lyon, France4 aut
700a Raponi, G.u Institute of Microbiology, Roma, Italy4 aut
700a Rankin, I.u Mount Sinai Medical Center, New York, NY, United States4 aut
700a Nicoletti, G.u Azienda Policlinico Univ. Catania, Catania, Italy4 aut
700a Fadda, G.u Policlinico Agostino Germelli, Rome, Italy4 aut
700a Hanberger, H.u University Hospital, Linkoping, Sweden4 aut
700a Rangel-Fausto, S.u Epiderniologia Hospitalaria, Mexico City, Mexico4 aut
700a Rodloff, A.C.u Institut fur Medizinische, Leipzig, Germany4 aut
700a Smyth, E.u Beaumont Hospital, Dublin, Ireland4 aut
700a Christiansen, K.u Inst. of Medical/Veterinary Science, Adelaide, NSW, Australia, Institute fur Hygiene/Mikrobiologie, Linz, Austria, Royal Perth Hospital, Pirth, Australia4 aut
700a Coombs, G.u Inst. of Medical/Veterinary Science, Adelaide, NSW, Australia, Institute fur Hygiene/Mikrobiologie, Linz, Austria, Royal Perth Hospital, Pirth, Australia4 aut
700a Kohno, S.u Nagasaki University, School of Medicine, Nagasaki, Japan4 aut
700a Miyazaki, Y.u Nagasaki University, School of Medicine, Nagasaki, Japan4 aut
700a Schmitz, F.J.u University Hospital Freiburg, Freiburg, Switzerland, Henreich-Heine University Dusseldorf, Dusseldorf, Germany4 aut
700a Fluit, A.C.u Eijkman-Winkler Inst. Med. Microbiol, Utrecht, Netherlands4 aut
700a Costa, D.u Milpark Hospital, Parktown, South Africa, University Hospital of Coimbra, Coimbra, Portugal4 aut
700a Appelbaum, P.u Hershey Medical Center, Hershey, PA, United States4 aut
700a Bruckner, D.u UCLA Medical Center, Los Angeles, CA, United States4 aut
700a Chaturvedi, V.u NYSDOH, Albany, NY, United States4 aut
700a Hall, G.u Cleveland Clinic Foundation, Ann Arbor, MI, United States4 aut
700a Kauffman, C.u VA Medical Center, Ann Arbor, MI, United States4 aut
700a Sobel, I.u Harper Hospital, Detroit, MI, United States4 aut
700a Suh, B.u Temple University, Philadelphia, PA, United States4 aut
700a Van, Horn K.u Van Horn, K., Westchester Medical Center, Valhalla, NY, United States4 aut
700a Finquelievich, J.u Scaolabrine Ortiz, Buenos Aires, Argentina4 aut
700a Tiraboschi, I.N.u Universiciad de Buenos Aires, Buenos Aires, Argentina4 aut
700a Colombo, A.L.u Rua Caiowa 854, Sao Paulo, Brazil4 aut
700a Crewe-Brown, H.H.u SAIMR, Johannesburg, South Africa4 aut
700a Roditi, D.u Groote Schuur Hospital, Observatory, South Africa4 aut
710a Department of Pathology, Roy J./Lucille A. Carver Coll. Med., University of Iowa, Iowa City, IA 52242, United States, Department of Medicine, Roy J./Lucille A. Carver Coll. Med., University of Iowa, Iowa City, IA 52242, United States, Department Epidemiology, Roy J./Lucille A. Carver Coll. Med., University of Iowa, Iowa City, IA 52242, United States, Medical Microbiology Division, Department of Pathology, Univ. of Iowa College of Medicine, Iowa City, IA 52242, United Statesb Department of Pathology, Roy J./Lucille A. Carver Coll. Med., University of Iowa, Iowa City, IA 52242, United States, Department of Medicine, Roy J./Lucille A. Carver Coll. Med., University of Iowa, Iowa City, IA 52242, United States4 org
773t Clinical Microbiology and Infectiond : Elsevier BVg 10:SUPPL. 1, s. 11-23q 10:SUPPL. 1<11-23x 1198-743Xx 1469-0691
856u http://www.clinicalmicrobiologyandinfection.com/article/S1198743X15300549/pdf
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-45812
8564 8u https://doi.org/10.1111/j.1470-9465.2004.t01-1-00844.x

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy